Position in IMTX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$353,911
-$139,712 QoQ
Shares Held
34,937
-30.4% QoQ
Ownership
0.023%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#54
of 83 holders
Holding Since
Jun 2023
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in IMTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026ExodusPoint Capital Management, LP holds $275,349,927 across 101 Biotechnology names. IMTX ranks #77 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CYTK |
Cytokinetics Inc
|
249,259 | $21,234,374 | |
| 2 | BBIO |
BridgeBio Pharma, Inc.
|
224,927 | $16,752,562 | |
| 3 | ORKA |
Oruka Therapeutics, Inc.
|
148,212 | $14,105,336 | |
| 4 | VKTX |
Viking Therapeutics, Inc.
|
361,126 | $14,087,525 | |
| 5 | JAZZ |
Jazz Pharmaceuticals plc
|
53,201 | $12,819,844 | |
| 6 | NAMS |
NewAmsterdam Pharma Co N.V.
|
304,334 | $10,313,879 | |
| 7 | TGTX |
Tg Therapeutics, Inc.
|
164,513 | $9,038,344 | |
| 8 | DNLI |
Denali Therapeutics Inc.
|
336,567 | $8,656,503 |
All Filings in IMTX
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $353,911 | 34,937 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $493,623 | 50,165 | Shares | Sole | 2026-05-14 | |
| 2025-03-31 | $339,593 | 75,298 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $441,367 | 62,077 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $5,151,341 | 451,476 | Shares | Sole | 2024-11-12 | |
| 2024-03-31 | $256,832 | 24,437 | Shares | Sole | 2024-05-14 | |
| 2023-09-30 | $1,406,958 | 121,499 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $1,354,692 | 117,391 | Shares | Sole | 2023-08-11 | |
| No filing history on record for this holder in this stock. | ||||||